A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma（LB2505-0001）
Clinical trial NCT07399444 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07399444
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-10
- Primary completion
- 2028-07-10
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.